Understanding how the tobacco industry affects health disparities related to tobacco use
Addressing disparities in tobacco-related diseases by understanding the tobacco industry strategies
This study looks at how tobacco companies market their products to minority communities and how this affects their health, especially with the rise of e-cigarettes and cannabis products, so we can create better policies to help those who are most at risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10897150 on NIH RePORTER |
What this research studies
This research investigates the ways in which the tobacco industry targets minority communities and contributes to health disparities associated with tobacco use. It focuses on understanding the marketing strategies and product offerings of tobacco companies, including the rise of electronic cigarettes and cannabis-related products. By analyzing these factors, the research aims to inform better tobacco control policies that address the unique challenges faced by vulnerable populations. The study will involve collecting data on tobacco use patterns and health outcomes among different demographic groups.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals from racial, ethnic, gender, and sexual orientation minorities, as well as those living below the poverty line or with lower educational attainment who use tobacco products.
Not a fit: Patients who do not use tobacco products or are not part of the targeted minority communities may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective tobacco control policies that reduce health disparities and improve outcomes for at-risk populations.
How similar studies have performed: Previous research has shown that understanding industry practices can lead to successful public health interventions, indicating that this approach has potential for meaningful impact.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Bialous, Stella Aguinaga — University of California, San Francisco
- Study coordinator: Bialous, Stella Aguinaga
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.